BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 31189709)

  • 21. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses.
    Gillen J; Li W; Liang Q; Avey D; Wu J; Wu F; Myoung J; Zhu F
    J Virol; 2015 May; 89(9):4918-31. PubMed ID: 25694600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.
    Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F
    J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
    Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
    J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interaction between ORF18 and ORF30 Is Required for Late Gene Expression in Kaposi's Sarcoma-Associated Herpesvirus.
    Castañeda AF; Glaunsinger BA
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
    Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
    Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
    J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Kaposi's Sarcoma-Associated Herpesvirus ORF31 with ORF34 and ORF24 Is Critical for Late Gene Expression.
    Brulois K; Wong LY; Lee HR; Sivadas P; Ensser A; Feng P; Gao SJ; Toth Z; Jung JU
    J Virol; 2015 Jun; 89(11):6148-54. PubMed ID: 25810551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the Open Reading Frame 49 Protein Encoded by Kaposi's Sarcoma-Associated Herpesvirus.
    Hew K; Veerappan S; Sim D; Cornvik T; Nordlund P; Dahlroth SL
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
    Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
    Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
    J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS
    J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
    Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.